Opportunity Information: Apply for CDC RFA DP13 1302

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.094 Well Integrated Screening and Evaluation for Women Across the Nation.
  • This funding opportunity was created on Mar 15, 2013 and posted on Mar 15, 2013.
  • Applicants must submit their applications by Apr 30, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $64,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
  • The number of recipients for this funding is limited to 21 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Eligibility Information 1. Eligible Applicants State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . American Indian/Alaska Native tribal governments (federally recognized or state recognized) American Indian/Alaska native tribally designated organizations 2. Special Eligibility Requirements Applicants must be recipients of the NBCCEDP program funding. Eligibility is limited by Congressional statute. WISEWOMAN is authorized under the National Breast and Cervical Cancer Early Detection Program to expand screening services inclusive of cardiovascular risks. The WISEWOMAN Program participants must be enrolled in the NBCCEDP to be eligible for WISEWOMAN services therefore, only organizations who are currently receiving NBCCEDP awards are eligible.
Apply for CDC RFA DP13 1302

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) grant opportunity (CDC RFA DP13-1302) is a Centers for Disease Control and Prevention cooperative agreement designed to expand and strengthen cardiovascular disease (CVD) risk screening, prevention, and follow-up services for underserved women by building directly on the infrastructure of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). The core idea is that women already being reached for breast and cervical cancer screening often also face elevated risks for hypertension, diabetes, and other cardiovascular risk factors, and WISEWOMAN uses that existing access point to add high-value heart health screening and connections to proven prevention and treatment supports.

The program’s purposes are organized around four main objectives. First, WISEWOMAN is intended to ensure that women ages 40 to 64 who are enrolled in NBCCEDP receive cardiovascular screening. In practical terms, this means integrating CVD-related assessments alongside or in coordination with NBCCEDP services so that eligible women can be screened for key cardiovascular risk factors in a systematic, program-supported way, rather than relying on sporadic or disconnected care.

Second, the opportunity emphasizes partnering with community-based organizations to deliver evidence-based prevention services for women who need risk reduction support. The announcement highlights formal agreements with organizations that can provide structured lifestyle and prevention interventions, with examples including the YMCA, Weight Watchers, and providers of Diabetes Prevention-type programs. This reflects a focus on using interventions that already have a research base and operational capacity, rather than asking grantees to invent new programs from scratch. It also signals that the program is meant to extend beyond the clinic by linking screened participants to real-world supports that can help with weight management, physical activity, nutrition, and diabetes risk reduction.

Third, WISEWOMAN prioritizes improving the management and control of hypertension through innovative health-system approaches and stronger community-clinical linkages. The announcement points to strategies such as team-based care and pharmacy medication management programs, both of which are commonly associated with improving blood pressure control by expanding the care team, improving medication adherence and optimization, and creating more consistent follow-up. This objective is not limited to identifying high blood pressure; it aims to strengthen how health systems and community partners work together so that hypertension is actually controlled over time.

Fourth, the program requires robust evaluation and reporting. Grantees are expected to gather and report program-related data, including impact measures. In other words, WISEWOMAN is structured not only as a service program but also as a performance-and-outcomes-driven initiative where participants, services delivered, follow-up actions, and measurable results are tracked and communicated back to CDC.

From a funding and administrative standpoint, this opportunity is a discretionary cooperative agreement in the health category. Cooperative agreement status matters because it generally implies substantial federal involvement compared with a standard grant, such as CDC technical assistance, collaboration on program implementation expectations, and closer monitoring of performance and reporting. The estimated total funding listed is $64,000,000, with an expected 21 awards. Individual award amounts are shown with a floor of $500,000 and a ceiling of $2,000,000. No cost sharing or matching requirement is indicated.

Eligibility is tightly defined by statute and program structure. Applicants must already be recipients of NBCCEDP funding, because WISEWOMAN participants must be enrolled in NBCCEDP to receive WISEWOMAN services. Eligible applicant types include state and local governments (or their bona fide agents), specified U.S. territories and freely associated states (including the District of Columbia, Puerto Rico, U.S. Virgin Islands, Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), as well as federally or state-recognized American Indian/Alaska Native tribal governments and tribally designated organizations. The practical effect is that WISEWOMAN is not an open competition for any nonprofit or university; it is targeted to public health entities and tribal organizations already operating NBCCEDP programs and able to integrate cardiovascular screening and follow-up into that established service pathway.

Key dates shown in the opportunity record indicate it was posted March 15, 2013, with an original and current closing date of April 30, 2013, and an archive date of May 30, 2013. The listing also provides a CDC Procurement and Grants Office contact (Technical Information Management Section) for applicants who had difficulty accessing the full announcement.

Overall, WISEWOMAN is a focused public health funding opportunity aimed at reaching women who may have limited access to preventive care, leveraging the NBCCEDP platform to add cardiovascular risk screening, and then ensuring the results lead somewhere meaningful through evidence-based community prevention programs, improved clinical hypertension management approaches, and strong evaluation and reporting so CDC can assess reach, quality, and health impact.

WISEWOMAN (CDC RFA DP13-1302) - Frequently Asked Questions

What is the WISEWOMAN grant opportunity?

The Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) opportunity (CDC RFA DP13-1302) is a Centers for Disease Control and Prevention (CDC) discretionary cooperative agreement intended to expand and strengthen cardiovascular disease (CVD) risk screening, prevention, and follow-up services for underserved women.

What is the main idea behind WISEWOMAN?

WISEWOMAN builds directly on the infrastructure of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). The concept is to use the existing access point created by breast and cervical cancer screening services to also screen for key heart health risks and connect women to proven prevention and treatment supports.

How does WISEWOMAN connect to NBCCEDP?

WISEWOMAN services are designed for women who are already enrolled in NBCCEDP. The program integrates cardiovascular screening alongside, or in coordination with, NBCCEDP services so screening and follow-up are systematic rather than sporadic or disconnected.

Who is the intended population served by WISEWOMAN?

The program focuses on underserved women ages 40 to 64 who are enrolled in NBCCEDP, with the goal of providing cardiovascular screening and appropriate prevention and follow-up services.

What are the major objectives of the WISEWOMAN program?

The opportunity is organized around four primary objectives:

  • Ensure women ages 40 to 64 enrolled in NBCCEDP receive cardiovascular screening.
  • Partner with community-based organizations to provide evidence-based prevention services.
  • Improve management and control of hypertension through innovative health-system approaches and stronger community-clinical linkages.
  • Conduct robust evaluation and reporting, including collecting and reporting program-related data and impact measures.

What types of health issues does WISEWOMAN emphasize?

WISEWOMAN emphasizes cardiovascular risk factors commonly affecting women reached through NBCCEDP, including risks related to hypertension and diabetes, as well as other cardiovascular disease risk factors addressed through screening, prevention, and follow-up.

Does the program require partnerships with community organizations?

Yes. The opportunity emphasizes formal agreements with community-based organizations to deliver evidence-based prevention services for women who need risk reduction support.

What are examples of community-based prevention partners mentioned in the announcement?

Examples listed include the YMCA, Weight Watchers, and providers of Diabetes Prevention-type programs. These examples reflect a preference for interventions with an existing research base and operational capacity.

Is the program focused only on screening, or also on follow-up and risk reduction?

It includes both. WISEWOMAN is meant to add heart health screening and ensure screened participants are linked to meaningful supports, including evidence-based prevention programs and stronger clinical/community connections for ongoing management.

What does WISEWOMAN prioritize regarding hypertension?

The program prioritizes improving the management and control of hypertension through innovative health-system approaches and stronger community-clinical linkages. The focus is not only on identifying high blood pressure, but on improving control over time.

What strategies are mentioned to improve hypertension control?

The announcement references approaches such as team-based care and pharmacy medication management programs as examples of strategies associated with improved blood pressure control.

What evaluation and reporting expectations are included?

WISEWOMAN requires robust evaluation and reporting. Grantees are expected to gather and report program-related data, including impact measures, to support performance and outcomes tracking.

What type of funding mechanism is WISEWOMAN?

WISEWOMAN is a discretionary cooperative agreement in the health category.

What does it mean that this opportunity is a cooperative agreement?

The cooperative agreement status generally indicates substantial federal involvement compared with a standard grant, such as CDC technical assistance, collaboration on implementation expectations, and closer monitoring of performance and reporting.

How much total funding is estimated for this opportunity?

The estimated total funding listed is $64,000,000.

How many awards are expected?

The opportunity lists an expected 21 awards.

What is the minimum and maximum award amount per recipient?

Individual award amounts are shown with a floor of $500,000 and a ceiling of $2,000,000.

Is cost sharing or matching required?

No cost sharing or matching requirement is indicated in the opportunity record.

Who is eligible to apply?

Eligibility is limited to entities that are already recipients of NBCCEDP funding, because WISEWOMAN participants must be enrolled in NBCCEDP to receive WISEWOMAN services.

What types of applicants are eligible under the announcement?

Eligible applicant types include state and local governments (or their bona fide agents), specified U.S. territories and freely associated states, and federally or state-recognized American Indian/Alaska Native tribal governments and tribally designated organizations.

Which territories and freely associated states are specifically listed as eligible?

The listing includes the District of Columbia, Puerto Rico, U.S. Virgin Islands, Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.

Can a nonprofit organization or university apply if it is not an NBCCEDP recipient?

Based on the information provided, the competition is not open to any nonprofit or university in general; it is targeted to public health entities and tribal organizations already operating NBCCEDP programs and able to integrate WISEWOMAN services into that pathway.

Why is eligibility tied to NBCCEDP funding?

The program structure requires that WISEWOMAN participants be enrolled in NBCCEDP to receive WISEWOMAN services, so applicants must already have NBCCEDP funding and the related service infrastructure.

When was this opportunity posted and when did it close?

The opportunity record indicates it was posted March 15, 2013. The original and current closing date shown is April 30, 2013.

Is this opportunity archived?

Yes. The archive date shown is May 30, 2013.

Who is the listed contact for access issues with the full announcement?

The listing provides a CDC Procurement and Grants Office contact (Technical Information Management Section) for applicants who had difficulty accessing the full announcement.

What is the overall purpose of WISEWOMAN in public health terms?

Overall, WISEWOMAN is intended to reach women who may have limited access to preventive care by leveraging the NBCCEDP platform to add cardiovascular risk screening, connect participants to evidence-based prevention programs, strengthen hypertension management through clinical and community linkages, and produce measurable results through required evaluation and reporting.

Browse more: Grants for Women

Browse more business programs for Women in Business

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Brook Trout Suppression in High Lake Upper Malheur River

Previous opportunity: Youth Internships

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA DP13 1302

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA DP13 1302) also looked into and applied for these:

Funding Opportunity
Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers 9th Announcement Apply for CMS 1A1 13 002

Funding Number: CMS 1A1 13 002
Agency: Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $3,000,000
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP13 1306

Funding Number: CDC RFA IP13 1306
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $400,000
State Offices of Rural Health Grant Program (SORH) Apply for HRSA 13 162

Funding Number: HRSA 13 162
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP13 1305

Funding Number: CDC RFA IP13 1305
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $250,000
Developing Research Capacity to Assess Health Effects Associated with Volcanic Emissions and other Environmental Exposures (R01) Apply for RFA EH 13 002

Funding Number: RFA EH 13 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention, Public Health Conference Support Apply for CDC RFA PS13 1305

Funding Number: CDC RFA PS13 1305
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
National Center for Environmental Health/Agency for Toxic Substances and Disease Registry Public Health Conference Support Program Apply for CDC RFA EH13 1306

Funding Number: CDC RFA EH13 1306
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $100,000
NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 13 144

Funding Number: PAR 13 144
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development of Animal Models and Related Biological Materials for Research (R21) Apply for PA 13 145

Funding Number: PA 13 145
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Promoting, Strengthening and Enhancing Disease Prevention by Collaboration with Targeted Stakeholders Apply for CDC RFA IP13 1303

Funding Number: CDC RFA IP13 1303
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $220,000
USAID/Vietnam Request for Information (RFI) on Healthy Markets Activity Apply for SOL 486 13 00022

Funding Number: SOL 486 13 00022
Agency: Thailand USAID Bangkok
Category: Health
Funding Amount: $15,000,000
Cooperative Centers on Human Immunology (U19) Apply for RFA AI 13 016

Funding Number: RFA AI 13 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,750,000
Limited Competition Dominantly Inherited Alzheimer Network (U19) Apply for PAR 13 147

Funding Number: PAR 13 147
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition Biomarkers for Older Controls at Risk for Dementia (BIOCARD) Study (U19) Apply for PAR 13 148

Funding Number: PAR 13 148
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Organizations for Chronic Disease Prevention Apply for CDC RFA DP10 10080401SUPP13

Funding Number: CDC RFA DP10 10080401SUPP13
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $230,000
NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 13 149

Funding Number: PAR 13 149
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Clinical Trial Planning Grant (R34) Apply for PAR 13 150

Funding Number: PAR 13 150
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
NIAID Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 13 151

Funding Number: PAR 13 151
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 13 152

Funding Number: PAR 13 152
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development and Characterization of Animal Models for Aging Research (R01) Apply for PA 13 155

Funding Number: PA 13 155
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP13 1302", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.